Search Results 1621-1630 of 20425 for hepatitis

1. Sumera I. Ilyas, M.B.B.S. - Doctors and Medical Staff - Mayo Clinic

   Alcoholic hepatitis · Autoimmune hepatitis · Cholangiocarcinoma; Chronic liver disease; Cirrhosis · Hemochromatosis · Hepatitis B · Hepatitis C · Hepatocellular ...

2. Gastroenterology and Hepatology - Doctors - Mayo Clinic

   Cirrhosis, Alcoholic hepatitis, Hepatic encephalopathy, Viral hepatitis. Show more areas of focus for Bashar A. Aqel, M.D.. Pagination Doctor search. Go to ...

3. Surgery - Doctors - Mayo Clinic

   Nonalcoholic fatty liver disease, Cirrhosis, Hepatitis C, Hepatitis B, Portal hypertension, Alcoholic hepatitis, Hepato...cellular carcinoma, Hepatic ...

4. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

   Known history of Human Immunodeficiency Virus (HIV), Hepatitis B (HBV) or untreated hepatitis C (HCV) infection. History of pulmonary alveolar proteinosis ...

5. Infectious Diseases Clinical Trials - Mayo Clinic Research

   The primary purpose of the study is to establish a long-term nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis ...

6. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

   Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies). Has known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV ...

7. A Study of the Effectiveness and Safety of Pembrolizumab (MK-3475) for Women with Advanced Recurrent Ovarian Cancer - Mayo Clinic

   Has known active Hepatitis B or Hepatitis C; Has received a live vaccine within 30 days of the planned first dose of the study. Participating Mayo Clinic ...

8. Surgery - Doctors - Mayo Clinic

   Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Nonalcoholic fatty liver disease, Cirrhosis, Alcoholic hepatitis, H...epatic encephalopathy, Portal ...

9. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   Serology and/or NAT indicating active hepatitis B virus (HBV) infection or carrier status for HBV (Note: A positive serology for HBV indicating a previous ...

10. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    Subjects with evidence of positive hepatitis B surface antigen (HBsAg) or hepatitis B core antibody (HBcAb). NOTE: if a subject tests negative for HBsAg ...